Your browser doesn't support javascript.
loading
[Metformin inhibits proliferation and promotes apoptosis of HER-2 positive breast cancer cells possibly through the Hippo-YAP pathway].
Xu, Y; Xu, T; Xiong, Y; Huang, J.
Afiliación
  • Xu Y; Department of Pathophysiology, College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.
  • Xu T; Department of Pathophysiology, College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.
  • Xiong Y; Department of Pathophysiology, College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.
  • Huang J; Department of Pathophysiology, College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.
Nan Fang Yi Ke Da Xue Xue Bao ; 42(5): 740-746, 2022 May 20.
Article en Zh | MEDLINE | ID: mdl-35673919
ABSTRACT

OBJECTIVE:

To investigate the effect of metformin on the proliferation and apoptosis of HER-2-positive breast cancer cell line SKBR3 and explore the possible mechanism of its action.

METHODS:

SKBR3 cells were treated with different concentrations (20-120 µmol/L) of metformin, and the changes in cell proliferation and colony formation ability were assessed using CCK-8 assay and crystal violet staining, respectively. Flow cytometry was performed to analyze cell apoptosis and cell cycle changes. Real-time fluorescent quantitative PCR (qRT-PCR) was used to detect mRNA expressions of YAP, TAZ, EGFR, CTGF, CYR61, E-cadherin, N-cadherin, vimentin and fibronectin in the treated cells, and the protein expressions of YAP and TAZ were detected using Western blotting; immunofluorescence assay was used to observe YAP/TAZ nuclear translocation in the cells.

RESULTS:

Metformin treatment significantly inhibited the proliferation of SKBR3 cells (P < 0.05) in a concentration- and time-dependent manner. The results of flow cytometry showed that metformin significantly promoted apoptosis and caused cell cycle arrest at G1 phase in SKBR3 cells. Metformin treatment significantly down-regulated the mRNA expressions of YAP, TAZ, EGFR, CTGF and CYR61, N-cadherin, vimentin and fibronectin (P < 0.05) and up-regulated the expression of E-cadherin (P < 0.05); Western blotting results showed that YAP and TAZ protein expressions were significantly down-regulated in the cells after metformin treatment (P < 0.05). Immunofluorescence assay revealed that metformin treatment caused the concentration of YAP and TAZ in the cytoplasm, and significantly reduced their amount in the cell nucleus.

CONCLUSION:

Metformin can inhibit proliferation and promote apoptosis and epithelal-mesenchymal transition of HER-2 positive breast cancer cells possibly by that inhibing YAP and TAZ expression and their nuclear localization.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Metformina / Neoplasias Idioma: Zh Revista: Nan Fang Yi Ke Da Xue Xue Bao Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Metformina / Neoplasias Idioma: Zh Revista: Nan Fang Yi Ke Da Xue Xue Bao Año: 2022 Tipo del documento: Article